Cargando…
Profound Sinoatrial Arrest Associated with Ibrutinib
BACKGROUND: Ibrutinib is a Bruton's tyrosine kinase (BTK) inhibitor approved for second-line treatment for mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and Waldenström macroglobulinemia. Ibrutinib use has been linked to increased incidence of atrial fibrillation and hypertens...
Autores principales: | Mathur, Kanupriya, Saini, Aditya, Ellenbogen, Kenneth A., Shepard, Richard K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742500/ https://www.ncbi.nlm.nih.gov/pubmed/29375920 http://dx.doi.org/10.1155/2017/7304021 |
Ejemplares similares
-
Distinct Effects of Ibrutinib and Acalabrutinib on Mouse Atrial and Sinoatrial Node Electrophysiology and Arrhythmogenesis
por: Tuomi, Jari M., et al.
Publicado: (2021) -
A case report of sinoatrial arrest caused by temporal lobe epilepsy in subclinical glioblastoma
por: Reifart, Jörg, et al.
Publicado: (2020) -
The Jailed Sinoatrial Node: An Interesting Case of Cardiogenic Shock
Secondary to Sinus Arrest Following Percutaneous Intervention
por: Ezeh, Ebubechukwu, et al.
Publicado: (2022) -
Profound Hypokalaemia Resulting in Maternal Cardiac Arrest: A Catastrophic Complication of Hyperemesis Gravidarum?
por: Walch, Anna, et al.
Publicado: (2018) -
Ibrutinib-induced cardiomyopathy
por: Kyi, Htay Htay, et al.
Publicado: (2019)